CRISPR Therapeutics AG (CRSP) Slipped -8.73% or -2.85 To Price $29.78 On Thursday


CRISPR Therapeutics AG (CRSP) slipped -8.73% or -2.85 to $29.78. It is approximately 912129 shares traded, which is 100.19% compare to the average total volume 910442. The market cap of CRSP is $1.55 billion. The year to date change is 0.51%. The 52 week price range is from $22.22 to $73.9. Price of CRSP have changed 0.62% during last week. It have changed 14.21% over last month, 4.32% over last 3 months, -30.80% over last 6 months and -26.49% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRSP is 33.03. It is 10.91% above current price. The 200-day Moving Averages for CRSP is 46.37. It is 55.71% above current price. The 52-week High is 73.9. It is 148.15% from the current price. The 52-week Low is 22.22. It is -25.39% from current price.

There are some statistics of CRSP. It is has market cap $1.55 billion. The share outstanding is 52.11 million. The average volume is 910442. The percent of top 15 Institution holding is 56.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRSP is -39.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRSP is -29.37%.


Tags:

Share this post